开放式论坛：抗生素的脆弱未来

January 21, 2026
18:30–19:45 (Europe/Amsterdam 时区)

关于本场会议

抗菌素耐药性正在动摇现代医学的根基。随着“超级细菌”的进化速度超越新药研发进程，曾经可治疗的感染正变得难以应对，威胁到外科手术到癌症治疗的方方面面。 我们该如何在提升全球救命抗生素可及性的同时，为未来世代保障这些药物的有效性？

发言人

SB
Stanley M. Bergman
Chairman of the Board and Chief Executive Officer
Henry Schein
RG
Rachel Glennerster
President
Center for Global Development
VL
Vanina Laurent-Ledru
Chief Public Health and Government Affairs Officer
Institut Mérieux
MM
Mosa Moshabela
Vice-Chancellor and Principal
University of Cape Town
DN
Deepak Nath
Chief Executive Officer
Smith+Nephew